İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - indacaterolum, glycopyrronium, mometasoni-17 furoas - hartkapsel mit pulver zur inhalation - indacaterolum 150 µg ut indacateroli acetas, glycopyrronium 50 µg ut glycopyrronii bromidum, mometasoni-17 furoas 160 µg, lactosum monohydricum 24..567 mg, magnesii stearas, kapselhülle: hypromellosum, carrageenanum, kalii chloridum, e 172 (flavum), e 132, aqua purificata, cera carnauba, drucktinte: aqua purificata, e 172 (nigrum), alcohol isopropylicus, propylenglycolum, hypromellosum pro capsula. - asthma - synthetika

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

chiesi sa - beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium - solution pour inhalation en flacon pressurisé - beclometasoni dipropionas 87.4 µg, formoteroli fumaras dihydricus 5.2 µg, glycopyrronii bromidum 10.9 µg corresp. glycopyrronium 9 µg, ethanolum anhydricum 8.856 mg, acidum hydrochloridum, norfluranum, ad aerosolum, pro dosi. - bronchopneumopathie chronique obstructive (bpco) (trimbow 87/5/9 mcg), asthme (trimbow 172/5/9 mcg) - synthetika

İsviçre - Almanca - Swissmedic (Swiss Agency for Therapeutic Products)

chiesi sa - beclometasoni dipropionas, formoteroli fumaras dihydricus, glycopyrronium - solution pour inhalation en flacon pressurisé - beclometasoni dipropionas 172.3 µg, formoteroli fumaras dihydricus 5 µg, glycopyrronii bromidum 10.6 µg corresp. glycopyrronium 9 µg, ethanolum anhydricum 8.856 mg, acidum hydrochloridum, norfluranum, ad aerosolum, pro dosi. - bronchopneumopathie chronique obstructive (bpco) (trimbow 87/5/9 mcg), asthme (trimbow 172/5/9 mcg) - synthetika

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

sintetica gmbh (8040737) - glycopyrroniumbromid (ph.eur.); neostigminmetilsulfat - injektionslösung - 0,5 mg/ml + 2,5 mg/ml - teil 1 - injektionslösung; glycopyrroniumbromid (ph.eur.) (09529) 0,5 milligramm; neostigminmetilsulfat (00113) 2,5 milligramm

Avrupa Birliği - Almanca - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Avrupa Birliği - Almanca - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

morningside healthcare (malta) limited (1005368) - tablette - 800 mikrogramm

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

morningside healthcare (malta) limited (1005368) - lösung zum einnehmen - 160 mikrogramm/ml

Almanya - Almanca - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

morningside healthcare (malta) limited (1005368) - tablette - 1600 mikrogramm